acetaZOLAMIDE
- Product NDC
- 70771-1827
- 11-digit product format
- 707711827
- Labeler code
- 70771
- Product ID
- 70771-1827_859b8e26-b64c-4d17-adbf-0251745c0510
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acetaZOLAMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA211069
- Marketing category
- ANDA
- Marketing start
- 2023-07-15
- Substance
- ACETAZOLAMIDE
- Active strength
- 125 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acetaZOLAMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 125 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 197303, 197304 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70771-1827-1 | acetaZOLAMIDE | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70771-1827 | ACETAZOLAMIDE TABLET [ZYDUS LIFESCIENCES LIMITED] | 2 | Current NDC, 1 package rows | 20230715_df84fea3-8947-403f-b470-1eeb6c4c293d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70771-1827-1 | 70771182701 | 100 TABLET in 1 BOTTLE (70771-1827-1) | 100 tablet | 2023-07-15 | No | No | Current |